Aspen Holdings News

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced interim financial results for the six months ended 31 December 2018 in line with management’s expectations. Stephen Saad, Aspen Group Chief Executive said, “Revenue increases from Anaesthetics in China and Latin America of 6% and 22% respectively…

Johannesburg: Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of EmdoltenTM, a Dolutegravir-based triple combination anti-retroviral (ARV) treatment option. EmdoltenTM, a once a day triple combination tablet therapy in the form of Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate, is positioned to become a preferred first line ARV and will…

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading global pharmaceutical company, has announced today, in conjunction with the announcement of its annual results for the year ended 30 June 2018, that it has concluded an agreement to divest of its global Nutritional Business to the Lactalis Group. Download (PDF 183KB)

Aspen was one of the few companies invited by French Prime Minister Edward Philippe to attend the Health Industry Strategic Meeting on 9 July 2018 at the Matignon, Paris – the official office of the Prime Minister. Represented by Stavros Nicolaou and Fabrice Jover, Aspen had an opportunity to hold brief discussions with Prime Minister…

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading global pharmaceutical company, is, for the eighth consecutive year, participating in Mandela Day through activities hosted by its businesses spanning 6 continents. Stephen Saad, Aspen Group Chief Executive said, “We heeded the Mandela Day call for the first time in 2011 and we…

Through public private partnership the Gauteng Department of Health and Chris Hani Baragwanath Academic Hospital (CHBAH) gave recognition to their Motor Neuron Disease (MND) clinic as a center of excellence to intensify its health care services. This is in response to a  desperate need to offer special care to patients who are suffering from this…

Port Elizabeth – JSE Limited-listed Aspen Pharmacare (APN), South Africa’s largest pharmaceutical company, officially opened its R1 billion Port Elizabeth-based high containment facility earlier today. Stephen Saad, Aspen Group Chief Executive said, “Aspen continues its evolution into a global specialty manufacturer of niche products requiring complex technologies. The high potency manufacturing facility we are opening…

Cape Town – JSE Limited-listed Aspen Pharmacare (APN), South Africa’s largest pharmaceutical company, was presented with the Economic Diplomacy (Africa) Award by the South African Government at the prestigious 4th annual Ubuntu Awards, held in Cape Town on 22 March 2018. Accepting the award from Lindiwe Sisulu, Minister of International Relations and Cooperations (“Dirco”) on…

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading global pharmaceutical company, has announced favourable results for the six months ended 31 December 2017. Aspen Interim Results release March 2018

Aspen Pharmacare billionaire Steven Saad opens up with the inside story of the fall of his shares. Exclusive on CNBC Africa first in business worldwide. CNBC Exclusive with Aspen CEO Stephen Saad from Aspen Pharmacare Pty Limited on Vimeo.